UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

Effects of codeine on pregnancy outcome: results from a large population-based cohort study

European journal of clinical pharmacology, 2011-12, Vol.67 (12), p.1253-1261

2011

Volltextzugriff (PDF)

Exploring a case of incompatibility in a complex regimen containing Plasma‐Lyte 148 in the pediatric intensive care

Pediatric anesthesia, 2023-03, Vol.33 (3), p.211-218

2023

Volltextzugriff (PDF)

Triptan Exposure During Pregnancy and the Risk of Major Congenital Malformations and Adverse Pregnancy Outcomes: Results From The Norwegian Mother and Child Cohort Study

Headache, 2010-04, Vol.50 (4), p.563-575

2010

Volltextzugriff (PDF)

Frequently acquired drugs in neonatal intensive care and their physical compatibility

Acta Paediatrica, 2022-12, Vol.111 (12), p.2307-2314

2022

Volltextzugriff (PDF)

Association of Prenatal Ibuprofen Exposure with Birth Weight and Gestational Age: A Population-Based Sibling Study

PloS one, 2016-12, Vol.11 (12), p.e0166971

2016

Volltextzugriff (PDF)

Pharmacological treatment of migraine during pregnancy and breastfeeding

Nature reviews. Neurology, 2015-04, Vol.11 (4), p.209

2015

Volltextzugriff (PDF)

Effect of prenatal selective serotonin reuptake inhibitor (SSRI) exposure on birthweight and gestational age: a sibling-controlled cohort study

International journal of epidemiology, 2016-12, Vol.45 (6), p.2018-2029

2016

Volltextzugriff (PDF)

Triptan safety during pregnancy: a Norwegian population registry study

European journal of epidemiology, 2013-09, Vol.28 (9), p.759-769

2013

Volltextzugriff (PDF)

Anti-PF4/polyanion antibodies in COVID-19 patients are associated with disease severity and pulmonary pathology

Platelets (Edinburgh), 2022-05, Vol.33 (4), p.640-644

2022

Volltextzugriff (PDF)

Neutrophil count predicts clinical outcome in hospitalized COVID‐19 patients: Results from the NOR‐Solidarity trial

Journal of internal medicine, 2022-02, Vol.291 (2), p.241-243

2022

Volltextzugriff (PDF)

Emulsion Stability of Different Intravenous Propofol Formulations in Simulated Co-Administration with Remifentanil Hydrochloride

Pharmaceutical technology in hospital pharmacy, 2019-08, Vol.4 (2), p.77-87

2019

Volltextzugriff (PDF)

Errata in "Triptan Exposure During Pregnancy and the Risk of Major Congenital Malformations and Adverse Pregnancy Outcomes: Results From the Norwegian Mother and Child Cohort Study"

Headache, 2012-09, Vol.52 (8), p.1319-1320

2012

Volltextzugriff (PDF)

Y-Site Physical Compatibility of Numeta G13E with Drugs Frequently Used at Neonatal Intensive Care

Pharmaceutics, 2020-07, Vol.12 (7), p.677

2020

Volltextzugriff (PDF)

Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial

Annals of internal medicine, 2021-09, Vol.174 (9), p.1261

2021

Volltextzugriff (PDF)

Co-administration of drugs with parenteral nutrition in the neonatal intensive care unit—physical compatibility between three components

European journal of pediatrics, 2022-07, Vol.181 (7), p.2685-2693

2022

Volltextzugriff (PDF)

Role and competencies of the EBMT clinical pharmacists and clinical pharmacologists: a pan-European survey

Bone marrow transplantation (Basingstoke), 2023-07, Vol.58 (7), p.829-831

2023

Volltextzugriff (PDF)

Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy-a guidance by the GoCART Coalition Pharmacist Working Group

Bone marrow transplantation (Basingstoke), 2023-10, Vol.58 (10), p.1069-1074

2023

Volltextzugriff (PDF)

Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9

Scientific reports, 2021-12, Vol.11 (1), p.23205-23205, Article 23205

2021

Volltextzugriff (PDF)

Co-administration of Intravenous Drugs: Rapidly Troubleshooting the Solid Form Composition of a Precipitate in a Multi-drug Mixture Using On-Site Raman Spectroscopy

Molecular pharmaceutics, 2023-06, Vol.20 (6), p.2853-2863

2023

Volltextzugriff (PDF)

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

Critical care (London, England), 2023-01, Vol.27 (1), p.9-9, Article 9

2023

Volltextzugriff (PDF)

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID‑19 (Bari‑SolidAct): a randomised, double‑blind, placebo‑controlled phase 3 trial

Critical care (London, England), 2023-12, Vol.27 (1)

2023

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(36)

Sprache

Englisch
(32)
Norwegisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Life Sciences & Biomedicine
(23)
Humans
(18)
Covid-19
(9)
Female
(9)
Adult
(7)
Pregnancy
(7)
General & Internal Medicine
(6)
Norway - Epidemiology
(6)
Sars-Cov-2
(6)
Infant, Newborn
(5)
Medicine, General & Internal
(5)
Original
(5)
Hematology
(4)
Immunology
(4)
Intensive Care
(4)
Migraine Disorders - Drug Therapy
(4)
Tryptamines - Adverse Effects
(4)
Abnormalities, Drug-Induced - Epidemiology
(3)
Analgesics
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Effects of codeine on pregnancy outcome: results from a large population-based cohort study

Exploring a case of incompatibility in a complex regimen containing Plasma‐Lyte 148 in the pediatric intensive care

Triptan Exposure During Pregnancy and the Risk of Major Congenital Malformations and Adverse Pregnancy Outcomes: Results From The Norwegian Mother and Child Cohort Study

Frequently acquired drugs in neonatal intensive care and their physical compatibility

Association of Prenatal Ibuprofen Exposure with Birth Weight and Gestational Age: A Population-Based Sibling Study

Pharmacological treatment of migraine during pregnancy and breastfeeding

Effect of prenatal selective serotonin reuptake inhibitor (SSRI) exposure on birthweight and gestational age: a sibling-controlled cohort study

Triptan safety during pregnancy: a Norwegian population registry study

Anti-PF4/polyanion antibodies in COVID-19 patients are associated with disease severity and pulmonary pathology

Neutrophil count predicts clinical outcome in hospitalized COVID‐19 patients: Results from the NOR‐Solidarity trial

Emulsion Stability of Different Intravenous Propofol Formulations in Simulated Co-Administration with Remifentanil Hydrochloride

Errata in "Triptan Exposure During Pregnancy and the Risk of Major Congenital Malformations and Adverse Pregnancy Outcomes: Results From the Norwegian Mother and Child Cohort Study"

High viral loads combined with inflammatory markers predict disease severity in hospitalized COVID‐19 patients: Results from the NOR‐Solidarity trial

Y-Site Physical Compatibility of Numeta G13E with Drugs Frequently Used at Neonatal Intensive Care

Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial

Co-administration of drugs with parenteral nutrition in the neonatal intensive care unit—physical compatibility between three components

Role and competencies of the EBMT clinical pharmacists and clinical pharmacologists: a pan-European survey

Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy-a guidance by the GoCART Coalition Pharmacist Working Group

Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9

High Circulating Levels of the Homeostatic Chemokines CCL19 and CCL21 Predict Mortality and Disease Severity in COVID-19

Co-administration of Intravenous Drugs: Rapidly Troubleshooting the Solid Form Composition of a Precipitate in a Multi-drug Mixture Using On-Site Raman Spectroscopy

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

Persistent T‐cell exhaustion in relation to prolonged pulmonary pathology and death after severe COVID‐19: Results from two Norwegian cohort studies

High circulating levels of the homeostatic chemokines CCL19 and CCL21 predict mortality and disease severity in Covid-19

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID‑19 (Bari‑SolidAct): a randomised, double‑blind, placebo‑controlled phase 3 trial

Suchergebnisse filtern